Eris Lifesciences Limited — QIP/Rights/Pref., 24-11-2025: Issue of Securities
24-11-2025 | 06:34 pm
24-11-2025 | 06:34 pm
Company will issue 23.06 lakh equity shares at ₹1,835.35 each via preferential allotment to Mr. Naishadh Shah to acquire the remaining 30% stake in subsidiary Swiss Parenterals for ₹423.30 Cr. This move aims for full ownership and operational synergy.
No comments yet. Be the first to comment!
